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Abstract
Recent studies underline the important role of microRNAs (miRNA) in the development of lung cancer. The main regulators
of miRNA biogenesis are the ribonucleases Drosha, Dicer and Ago2. Here the role of core proteins of miRNA biogenesis
machinery in the response of human non-small and small cell lung carcinoma cell lines to treatment with ionizing radiation
was assessed. We found that Drosha and Dicer were expressed at higher levels in radioresistant but not in sensitive cell lines.
However, down-regulation of either Dicer or Drosha had no effect on the sensitivity of cells to irradiation. Elimination of
components of the RNA-induced silencing complex Ago2 and Tudor staphylococcal nuclease also did not sensitize cells to
the same treatment. Thus, modulation of miRNA biogenesis machinery is not sufficient to increase the radiosensitivity of
lung tumors and other strategies are required to combat lung cancer.
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Introduction
Lung cancer (LC) is a leading cause of cancer mortality
worldwide in both women and men. There are two main types
of this neoplasia, small cell lung carcinoma (SCLC) and non-
small cell lung carcinoma (NSCLC), which differ considerably in
their histopathological features and responses to therapy.
Ionizing radiation, alone or in combination with surgery or
chemotherapy, is an effective treatment for many cancers,
including LC. However, both intrinsic and acquired tumor
radioresistance greatly reduce the efficacy of radiotherapy for
NSCLC and SCLC and often lead to relapse and metastasis.
Therefore, it is of great importance to explore the molecular
mechanisms underlying the resistance of LC cells to radiation.
MicroRNAs (miRNA), non-protein coding, single-stranded
RNAs of 19–25 nucleotides, constitute a novel class of gene
regulators and have been reported to play a critical role in
cancer transformation [1]. Recent studies demonstrated the
aberrant expression of miRNAs in LC [2-5]. The production of
miRNAs requires a set of proteins collectively referred to as the
miRNA machinery. Aberrant expression of components of the
miRNA machinery has been implicated in tumorigenesis,
including LC [6,7]. Up-regulation of Dicer in lung adenocar-
cinoma and its possible role in the development of peripheral
adenocarcinomas have been reported [7]. High expression of
other RNA-induced silencing complex (RISC) proteins, fragile
X mental retardation syndrome-related protein 1 (FXR1),
Tudor-SN (TSN) and protein activator of the interferon-induced
protein kinase (PACT), have been demonstrated in SCLC [7].
Another group described an association between reduced Dicer
expression and poor prognosis in LC patients [8]. Thus,
additional investigations are required to further elucidate the
role of miRNA machinery in the molecular pathogenesis of LC.
Recently, the potential therapeutic effect of Dicer depletion on
the chemosensitivity and proliferation of breast cancer cells has
been reported. The knock-down of Dicer by siRNA led to
significant G1 arrest and increased sensitivity to the DNA-
damaging agent, cisplatin, in the breast cancer cell line MCF-7
[9]. Given the fundamental and multiple biological roles of
miRNAs in different cellular processes, the modulation of
expression of proteins involved in miRNAs biogenesis might be
a promising therapeutic approach for further clinical applica-
tion. To date there are no data concerning the role of miRNA-
producing proteins in mechanisms of resistance/sensitivity of LC
cells to treatment. Therefore, we investigated whether the
depletion of core proteins involved in miRNAs biogenesis
influences the resistance of LC to radiotherapy. Surprisingly,
knock-down of expression of Drosha, Dicer, Argonaute2 and
Tudor-SN by RNA interference did not increase the sensitivity
of NSCLC cells that were resistant to treatment with ionizing
radiation.
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Cell Culture and Treatments
Human NSCLC cell lines U1810, U1299 (both from the UU
collection), A549, H661, H157, H23 (all from the ATCC); and
SCLC cell lines H69 (ECACC), H82 (ATCC), U1906, U1690,
U2020, U1285 (all from the UU collection) were maintained in
RPMI 1640 medium supplemented with 10% heat-inactivated
fetal bovine serum (FBS), glutamine (2 mM), penicillin (100 U/ml)
and streptomycin (100 mg/ml) (all obtained from Gibco) at 37uC,
5% CO2 and 95% humidity. Cells were exposed to irradiation at a
dose of 8 Gy using a
60Co source (Karolinska Biomics Center,
Karolinska University Hospital) for the periods indicated in the
figure legends.
Evaluation of Apoptosis
Apoptosis was determined by the amount of cells in the sub-G1
phase. The cells were trypsinized and resuspended in phosphate
buffered saline (PBS) containing 0.1% FBS. A total of 1610
6 cells
were used for analysis. Cells were pelleted at 2000 rpm and
washed once in PBS. The pellet was resuspended in 250 mL ice-
cold PBS and mixed with 2 mL ice-cold 70% ethanol dropwise
while vortexing. Samples were kept at 4uC for 24 h and afterwards
pelleted at 2000 rpm and washed twice with PBS. After the last
wash the cells were resuspended in 360 mL PBS containing
100 mg/mL RNase-A (Fermentas) and incubated at 37uC for 1 h.
Forty mL of propidium iodide solution (stock at 0.5 mg/mL) was
added to the samples followed by incubation for 30 min at room
temperature with gentle swinging and protection from light. Cells
were analyzed by flow cytometry (FACScan, Becton Dickinson),
and data were evaluated using Cell Quest software.
Caspase Activity Assay
Cells were washed with ice-cold PBS, resuspended in 25 mL
PBS, lysed by freezing in liquid nitrogen, incubated with caspase-
3-like substrate and analyzed as described previously [10]. Caspase
activity was expressed as the fold of increase relative to appropriate
controls.
siRNA Transfection
siRNAs targeting human Dicer1, Drosha, Argonaute2 and non-
targeting siRNA as a negative control were obtained from Thermo
Scientific DharmaconH and stored at a concentration of 20 mM.
Twenty-four hours before transfection cells were seeded onto 6-
well plates in growth media without antibiotics. siRNAs were
diluted in 100 mL RPMI 1640 medium (Gibco) and mixed with
1 mL DharmaFECTH1 siRNA Transfection Reagent (Thermo
Scientific DharmaconH). After 20 min of incubation, the
complexes were added to the cells to give a final concentration
of siRNAs in the medium of 50 nM. Forty-eight hours after
transfection, the medium was replaced and cells were subjected to
irradiation.
Western Blot Detection
Cells were lysed using Complete lysis buffer (Roche) plus
protease inhibitor cocktail (PIC, Complete-M, Roche). The
protein concentration was determined using the BCA protein
assay (Pierce). After mixing with Laemmli’s buffer, samples were
subjected to SDS-PAGE and Western blotting. For immunodetec-
tion, the following antibodies were used: anti-Dicer, anti-cleaved
PARP, anti-cleaved caspase-3, anti-cleaved caspase-9 (all obtained
from Cell Signaling Technology), anti-Ago2, anti-Drosha (both
from Millipore), anti-XPO5, anti-PRKRA (PACT) (both from
Abnova), anti-FXR1 (Santa Cruz Biotechnology), anti-b-actin
(Sigma-Aldrich), and anti-GAPDH (Trevigen). Horseradish per-
oxidase-labeled anti-mouse or anti-rabbit secondary antibodies
(Pierce) and an enhanced chemiluminescence kit (Western blot
detection reagent, GE Healthcare UK Limited) were used for the
detection of recognized proteins. Densitometric analysis for
quantification of the relative level of protein expression was
performed using ImageJ software (http://rsbweb.nih.gov/ij/).
Real-Time Quantitative PCR
RNA was isolated from cells using a PureLink
TM RNA Mini Kit
(Invitrogen). Reverse-transcribed cDNAs from the samples were
used as templates. Argonaute2 (Ago2-left ctaccttcccctggaggtctg
and Ago2-right cgacctagcagtcgctctga) and 18S ribosomal RNA
(18S-1 cgctactaccgattggatggtt and 18S-2 agtcaagttcgaccgtcttctc)
primers (Invitrogen) were designed to match the target cDNA
sequence. Twenty ng of the reverse-transcribed cDNA template
was mixed with SYBRH Green PCR Master Mix (Applied
Biosystems) and amplified using a 7500 Real-Time PCR System
(Applied Biosystems) with the following program: 40 cycles, with
each cycle consisting of a denaturation step at 95uC for 15 s and an
annealing/extension step at 60uC for 1 min.
Statistical Evaluation
The results of three independent experiments were expressed as
the mean 6 S.E.M. Statistical evaluation was performed using a
non-paired t-test.
Results
Expression of Proteins Involved in miRNA Biogenesis in
NSCLC and SCLC
In order to identify molecular targets for the radiosensitization
of LC cells among proteins involved in miRNA biogenesis we
performed a protein expression analysis of seven core miRNA
machinery components in a panel of NSCLC and SCLC (six cell
lines in each panel). For each LC subtype the cell lines were
selected based on their radiosensitivity, as measured by the
fraction surviving after exposure to 2 Gy (SF2) in a clonogenic
survival assay, and grouped into radiosensitive (RS) with SF2 ,
0.3 Gy or radioresistant (RR) with SF2 $ 0.3 Gy [11-14]. The
basal levels of all proteins (Drosha, Dicer, exportin-5 (XPO5),
Tudor-SN (TSN), protein activator of the interferon-induced
protein kinase (PACT), fragile X mental retardation syndrome-
related protein 1 (FXR1) and Argonaute2 (Ago2) were assessed by
Western blot in all selected cell lines prior to irradiation
(Figure 1A). Both RNase III enzymes (Drosha and Dicer) were
expressed at relatively high levels in NSCLC cells compared with
SCLC. A member of the karyopherins protein family, XPO5,
which is involved in the nuclear export of miRNAs, was expressed
at a higher level in H661 while low levels of expression were seen
in H69 and U1690 compared to the remaining cell lines. The level
of expression of TSN, PACT, FXR1 and Ago2 proteins did not
vary profoundly among the various cell lines, with the exception of
H69, which exhibited lower expression of all of the studied
proteins. As our panel consisted of both RS and RR cells, the H23
cell line was selected as the representative of radiosensitive cells,
and U1810 and H661 were used as representatives of radioresis-
tant cells in further investigations. Densitometric analysis of
protein expression revealed that Dicer, Drosha and XPO5 were
expressed at higher levels in RR cells compared to RS, whereas
there was no clear correlation between the levels of expression of
Ago2, TSN, PACT and FXR1 and SF2 values (Figure 1B).
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To further investigate the role of miRNA machinery compo-
nents in the response of LC cells to irradiation, two RR cell lines
(U1810 and H661) and one RS line (H23) from the panel of
NSCLC were subjected to gamma irradiation and protein
expression was analyzed 6, 24 and 48 h after treatment. As
expected, massive apoptotic cell death was observed in H23 at 6 h
after ionizing radiation, as assessed by the cleavage of PARP,
whereas H661 and U1810 responded to treatment at later time
points after 24 and 48 h, respectively (Figure 2). No visible changes
in expression of any of the studied proteins were detected either in
RR or RS cells, as measured by Western blot at 6, 24 and 48 h
after IR treatment (Figure 2). Thus, gamma irradiation does not
affect the expression of core proteins of the miRNA machinery in
NSCLC regardless of the RR or RS phenotype of these cancer
cells.
Knock-down of Core Proteins Involved in the First Step of
miRNA Biogenesis is not Sufficient to Sensitize NSCLC
Cells to Irradiation
Since the level of protein expression of at least three miRNA
machinery components, Dicer, Drosha and XPO5, was positively
correlated with the radioresistance of NSCLC cells, the high level
of their expression may contribute to the tumor cells’ response to
treatment in a miRNA-guided fashion. To explore this possibility
we decided to investigate the potential sensitizing effect of down-
regulation of Dicer and Drosha proteins in the U1810 cell line.
The nuclear ribonuclease Drosha and the cytoplasmic ribonucle-
ase Dicer are the two main regulators of the first step of miRNA
production and promote the cleavage of long primary transcripts
into the hairpin intermediates (pre-miRNAs) and subsequent
cleavage into mature miRNAs. Thus, by eliminating either of
these two core proteins we expected to reduce miRNA production
and affect the radioresistance of NSCLC cells.
The knock-down of Dicer in U1810 cells was performed using
RNA interference, after which the cells were subjected to gamma
irradiation and analyzed 48 h after treatment. The complete
silencing of Dicer protein expression was confirmed by Western
blot before and after irradiation (Figure 3A). Down-regulation of
Dicer was followed by decreased production of several miRNAs
(miR1301, miR1249, miR1227, miR532-3p, miR625, miR1827,
miR324-5p) as assessed by real-time PCR (data not shown).
However, U1810 cells with depleted Dicer exhibited as strong
response to ionizing radiation as did wild-type cells. There were no
differences in the cleavage of PARP between control and Dicer
knocked-down cells (Figure 3A). The percentage of apoptotic cells
after irradiation was the same in all studied groups (Figure 3B).
Analysis of activation of caspases showed that caspase-3 and -9
were equally processed after irradiation and that caspase-3-like
activity was almost identical in both wild-type and Dicer-depleted
cells (Figure 3A and C). A similar effect on radioresistance was
apparent when Drosha was depleted in U1810 cells. No changes in
PAPR cleavage (Figure 3D) or the number of apoptotic cells
(Figure 3E) were detected among control and Drosha knocked-
down cells 48 h after ionizing radiaiton. Similar results were
obtained following the elimination of Dicer and Drosha from other
NSCLC cell lines (Figure S1 and S2). Overall these data suggest
that knock-down of either Dicer or Drosha was not sufficient to
sensitize NSCLC cells to gamma irradiation.
Down-regulation of Main Components of RNA-induced
Silencing Complex (RISC) does not Sensitize NSCLC Cells
to Irradiation
Since the depletion of core proteins of the first step of miRNA
biogenesis did not affect the radiosensitivity of NSCLC, it is
possible that RNA interference-mediated knock-down of either
Dicer or Drosha results in a significant reduction, but not the full
Figure 1. NSCLC and SCLC cells differ in sensitivity to radiation treatment and display differential expression of proteins involved
in the regulation of miRNA biogenesis. (A) Western blot analysis of the level of protein expression of Drosha, Dicer, exportin 5 (XPO5), Tudor-SN
(TSN), protein activator of the interferon-induced protein kinase (PACT), fragile X mental retardation syndrome-related protein 1 (FXR1) and
Argonaute 2 (AGO2) in a panel of NSCLC (U1810, U1299, A549, H661, H157, H23) and SCLC (U1285, H82, H69, U1690, U1906, U2020) cell lines. (B)
Densitometric analysis of relative levels of protein expression in H23, H1299, U1810 and H661 cell lines. Cell lines distributed according to
radiosensitivity, measured as the fraction surviving at 2 Gy (SF2). Equal loading was verified using anti-b-actin antibodies. Results are representative of
three independent experiments.
doi:10.1371/journal.pone.0033134.g001
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molecules. miRNAs are stable once they enter into the effector
complex. Therefore, we decided to block the second step of
miRNA biogenesis by knock-down of the two main components of
RISC, Argonaute2 and Tudor-SN, and thus establish their role in
the radioresistance of LC cells. The effective down-regulation of
expression of Ago2 in the U1810 cell line was confirmed by
measuring its mRNA expression, which was reduced by up to 95%
after transfection with anti-Ago2 siRNA (Figure 4A). Nevertheless,
the apoptotic response (assessed by PARP cleavage and processing
of caspase-3 and -9) exhibited by Ago2-depleted cells after
irradiation was as strong as in the wild-type U1810 cells
(Figure 4B). Additionally, there were no significant changes in
the percentage of the sub-G1 population or the activation of
caspase-3 after ionizing radiation, although both parameters were
slightly decreased in Ago2-down-regulated cells compared to wild-
type cells (Figure 4C and D).
Finally, the same set of experiments was conducted in order to
knock-down the expression of another RISC component, Tudor-
SN. Besides its function as a component of the multiprotein
complex involved in miRNA functioning, TSN is known to act as
a transcriptional activator and oncogene in many cancers.
Additionally, it is cleaved during apoptosis. Even though
significant down-regulation of TSN expression using siRNA was
achieved in U1810 cells, as shown by Western blot analysis, the
knocked-down cells exhibited similar cleavage of PARP as the
wild-type upon ionizing radiation treatment (Figure 5A). The
percentage of apoptotic cells did not differ between control and
TSN knocked-down groups after irradiation (Figure 5B). Similar
results were obtained for two other cell lines from the NSCLC
panel (A549 and H661) after down-regulation of TSN (Figure 5C
and D).
Discussion
Radiotherapy is a major therapeutic weapon in LC. However,
the effectiveness of this type of therapy is limited by the initial or
acquired radioresistance of the tumor cells. NSCLC is character-
ized by a low tumor response rate to irradiation and a 5-year
survival rate of only 7% to 10% [15]. SCLCs initially respond well
to conventional chemo- and radiotherapy, but develop acquired
chemo- and radioresistance over the subsequent 3 to 12 months,
and the overall 5-year survival rate is only 5% [16]. The
mechanisms leading to the radioresistance of these tumors are
not yet fully understood.
miRNAs have been reported to be potential diagnostic or
therapeutic targets in cancer treatment, including lung tumors.
There is increasing evidence of the association between miRNA
expression in tumors and chemo- and radiosensitivity, both with
regards to predicting and modulating sensitivity [17-20]. A recent
study on NSCLC identified a subset of miRNAs showing robust
changes in expression in response to irradiation. Thus, a global
miRNA response does exist in all tumor cells, including lung
cancer, and miRNAs might be components of the cellular
response to cytotoxic insult [20]. Similar findings concerning the
changes in global miRNA expression were reported after
anticancer treatment with various chemotherapeutic drugs in
different cancer cell lines and patient samples [21]. The expression
of the miRNA processing components was shown to be
deregulated in different human cancers [8,22,23] and, thus, might
contribute to tumor cells’ response to treatment in a miRNA-
guided fashion or independently of the RNA interference
pathway. Down-regulation of Dicer in MCF-7 breast cancer cell
line by siRNA was shown to cause G1 arrest and increase
sensitivity to the DNA-damaging agent, cisplatin, suggesting that
the combination of the anti-Dicer strategy and traditional
chemotherapy could improve the efficiency of cancer treatment
[9]. Another study demonstrated that Dicer down-regulation can
increase the proliferative and invasive ability of tumor cells in vitro
and similarly promote subcutaneous tumor xenograft proliferation
in vivo [24]. Overall, these data suggest that miRNA machinery
plays either a negative or positive role in tumor transformation
and response to therapy in different types of cancer. In the present
study, we aimed to clarify the role of miRNA biogenesis
components in the modulation of radiation response in NSCLC
and SCLC cell lines. In order to identify molecular targets for
radiosensitization, the protein expression analysis of seven core
proteins of the miRNA machinery, Drosha, Dicer, XPO5, TSN,
PACT, FXR1 and Ago2, was performed in a panel of NSCLC
and SCLC cell lines. Our findings demonstrated the higher
Figure 2. Expression of components of miRNA machinery in NSCLC following treatment with ionizing radiation. The cleavage of PARP
and the level of expression of Drosha, Dicer, exportin 5 (XPO5), Tudor-SN (TSN), protein activator of the interferon-induced protein kinase (PACT), and
fragile X mental retardation syndrome-related protein 1 (FXR1) in U1810, H661 and H23 cells were detected by Western blot at 6, 24 and 48 h post-
irradiation with 8 Gy. Equal loading was verified using anti-b-actin antibodies. Data are representative of three independent experiments.
doi:10.1371/journal.pone.0033134.g002
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radiation compared to sensitive lines. However, knock-down of
these two essential proteins did not affect the sensitivity of NSCLC
cells to treatment with gamma irradiation. This may partially be
due to the long half-life of mature miRNA. Several studies have
shown that RNA interference-mediated knock-down of Drosha,
XPO5-5 or Dicer results in a significant reduction, but not the full
loss, of mature miRNA [25-28]. Since miRNAs seem to be quite
stable once they enter into the effector complex, we explored the
possibility of increasing the radiosensitivity of lung tumor cells by
the depletion of down-stream components of the miRNA
biogenesis pathway, i.e., two main RISC proteins, Ago2 and
Tudor-SN. Nevertheless, down-regulation of these proteins did not
affect the sensitivity of NSCLC cells to treatment. So, there may be
alternative biogenesis pathway(s) that can be activated upon
disruption of one of the multiple steps in the canonical miRNA
biogenesis process. Some miRNAs were found to be generated via
a Dicer-independent biogenesis pathway: after being processed by
Drosha, the pre-miRNAs can be directly loaded to Ago and
cleaved by the Ago catalytic center to generate an intermediate 3`
end, which is further trimmed [29]. There is also a class of non-
canonical miRNAs that bypass the Drosha microprocessor, but
still require Dicer for their biogenesis [30]. It should be noted that
analysis of the protein expression of all core components of the
miRNA machinery in U1810 cells performed after down-
regulation of Dicer, Drosha, TSN or Ago2 revealed that neither
of the knock-downs had a significant effect on the expression of
other proteins in the pathway, i.e. we observed no increase in the
expression of miRNA machinery components following knock-
downs (Figure S3). On the other hand, a recent study performed
Figure 3. Knock-down of Dicer and Drosha is not sufficient to sensitize NSCLC cells to irradiation. (A) The level of Dicer expression,
cleavage of PARP and processing of caspase-3 and -9 in U1810 cells transfected (48 h) with control (si scr) or Dicer (siDicer) siRNA assessed by Western
blot 48 h after irradiation. Equal loading was verified using anti-GAPDH antibodies. Data are representative of three independent experiments. (B)
Detection of apoptotic cell death in U1810 assessed by measuring the sub-G1 population after transfection (48 h) with control or Dicer siRNA and
irradiation treatment (48 h). (C) Caspase-3-like activity (fold increase with respect to control) in U1810 cells after treatment with either irradiation
alone or in combination with transfection of control or Dicer siRNA (for details see Materials and methods). (D) The level of Drosha expression and
cleavage of PARP in U1810 cells transfected (48 h) with control (si scr) or Drosha (siDrosha) siRNA analyzed by Western blot 48 h after treatment with
irradiation. Equal loading was verified using anti-GAPDH antibodies. All data are representative of three independent experiments. (B) Apoptotic cell
death in U1810 measured by analysis of the sub-G1 population after transfection (48 h) with control or Drosha siRNA and irradiation treatment (48 h).
Results shown are the mean6S.E.M. of three independent experiments.
doi:10.1371/journal.pone.0033134.g003
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suppression of miRNA expression achieved through down-
regulation of either Ago2 or Dicer proteins using siRNA led to
increased cell death after irradiation [31]. This indicates that the
contribution of the miRNA machinery to the response to
radiotherapy might highly depend on cell type and be different
in normal and cancer cells.
Another report showed that miRNA biogenesis is globally
induced upon DNA damage in an ataxia-telangiectasia mutated
(ATM) kinase-dependent manner in mouse embryonic fibroblasts
(MEFs) after treatment with the radiomimetic drug neocarcinos-
tatin (NCS), which generates double-strand breaks (DSBs). KH-
type splicing regulatory protein (KSRP) was found to be a key
player that translates DNA damage signaling to miRNA
biogenesis. The ATM kinase directly binds to and phosphorylates
KSRP, leading to enhanced interaction between KSRP and pri-
miRNAs and increased KSRP activity in miRNA processing [32].
Whether KSRP is activated and contributes to miRNA processing
in NSCLC upon the down-regulation of core components of the
miRNA machinery and treatment with gamma irradiation
remains to be clarified.
Additionally, it is known that most miRNAs have dozens to
hundreds of targets, and that target mRNAs may bind multiple
miRNAs. Perhaps the magnitude of decrease in miRNA
production and activity caused by the elimination of a single
protein from a miRNA pathway is not enough to affect the
mechanisms responsible for the resistance of LC cells to irradiation
treatment. In other words, it is likely that a real impact on the
radioresistance of NSCLC cells via the miRNA machinery cannot
be achieved by the elimination of single proteins from the
biogenesis pathway, and thus further identification and targeting
of particular miRNAs involved in the response of LC cells to
irradiation therapy is required.
In summary, in the present study the expression of a set of
proteins involved in miRNA biogenesis was assessed for the first
time in a panel of human LC cell lines. Even though the
expression of core proteins of the miRNA pathway correlated with
the resistance of cells to radiotherapy, the knock-down of these
proteins was not sufficient to trigger the sensitization of LC cells to
this type of treatment. This suggests that lung tumor radioresis-
tance cannot be overcome by modulation of the miRNA
biogenesis machinery and that other strategies are required to
combat lung cancer.
Supporting Information
Figure S1 The expression of Dicer and PARP cleavage in A549
and H661 cells transfected with control (si scr) or Dicer (si Dicer)
siRNA analyzed by Western blot 48 h after treatment with
irradiation (A). Equal loading was verified using anti-GAPDH
antibodies. (B) Apoptotic cell death in A549 and H661 cells
measured by analysis of the sub-G1 population after transfection
Figure 4. Depletion of a component of the RNA-induced silencing complex (RISC), Argonaute2, does not affect the radioresistance
of NSCLC. (A) The level of Argonaute2 (AGO2) mRNA in U1810 cells transfected with control (scram) or AGO2 siRNA normalized against 18S
ribosomal RNA. Results are the mean6S.E.M. of three independent experiments. (B) Cleavage of PARP and processing of caspase-3 and -9 in U1810
cells transfected (48 h) with control (si scr) or AGO2 siRNA, and then subjected to irradiation for 48 h. Equal loading was verified using anti-GAPDH
antibodies. All data are representative of three independent experiments. (C) Detection of apoptotic cell death in U1810 cells after transfection (48 h)
with control or AGO2 siRNA and subsequent treatment with irradiation (48 h). (D) Caspase-3-like activity (fold increase with respect to control) in
U1810 cells after treatment with either irradiation alone or in combination with transfection with control or AGO2 siRNA. All results shown are the
mean6S.E.M. of three independent experiments.
doi:10.1371/journal.pone.0033134.g004
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(48 h).
(TIF)
Figure S2 The level of Drosha and cleaved PARP in A549 (A)
and H661 (C) cells after knock-down of Drosha. Equal loading was
verified using anti-GAPDH antibodies. (B) The percentage of
apoptotic cells in A549 transfected with Drosha siRNA and treated
with irradiation (48 h). (D) Caspase-3-like activity (fold increase
with respect to control) in H661 cells after treatment with either
irradiation alone or in combination with transfection with control
or Drosha siRNA.
(TIF)
Figure S3 The level of Drosha, Dicer, XPO5, TSN, PACT
after knock-down of Dicer, Drosha, TSN and Ago2 in U1810
cells. Equal loading was verified using anti-GAPDH antibodies.
(TIF)
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